Loading…

Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment

Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review o...

Full description

Saved in:
Bibliographic Details
Published in:Transplant infectious disease 2014-04, Vol.16 (2), p.270-278
Main Authors: Schieffelin, J.S., Garcia-Diaz, J.B., Loss Jr, G.E., Beckman, E.N., Keller, R.A., Staffeld-Coit, C., Garces, J.C., Pankey, G.A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3
cites cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3
container_end_page 278
container_issue 2
container_start_page 270
container_title Transplant infectious disease
container_volume 16
creator Schieffelin, J.S.
Garcia-Diaz, J.B.
Loss Jr, G.E.
Beckman, E.N.
Keller, R.A.
Staffeld-Coit, C.
Garces, J.C.
Pankey, G.A.
description Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009. Methods Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses. Results The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses. Conclusions As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.
doi_str_mv 10.1111/tid.12197
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1520388931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1520388931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</originalsourceid><addsrcrecordid>eNqNkU9vFCEYhydGY__owS9gJvFSk07LCwwD3pqqa5Om9rDVxAthGdilzsAIM6nz7WW7bQ8mJnLhDTzPL5BfUbwBdAJ5nY6uPQEMonlW7AMRoiKI4ef3M68wbshecZDSLULQCCpeFnuYMsw5EvvFfL1RJmzmYRP6WYfkUmknv1Zd6bw1enTBpzyWKXSuLUNcK1-OUfk0dMqPZTTaDc74MX0odee809kcokn5SG3l43JQ4yZ0YT0fl8q3WTZq7PP1q-KFVV0yrx_2w-Lm86fl-Zfq8uvi4vzsstJUoKZSlCvNjOaCEwFIMQuIEVKvcM3BWm5Ua6lVRgtLG6IJBdBM14AxsxjQihwWR7vcIYZfk0mj7F3SpsvvN2FKEmqMCOeCwH-gQCmhDeCMvvsLvQ1T9PkjW4oQELhhmXq_o3QMKUVj5RBdr-IsAcltdTJXJ--ry-zbh8Rp1Zv2iXzsKgOnO-DOdWb-d5JcXnx8jKx2hkuj-f1kqPhTsoY0tfx-tZD46hshC_pDLskfzkizMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1513319276</pqid></control><display><type>article</type><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</creator><creatorcontrib>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</creatorcontrib><description>Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009. Methods Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses. Results The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses. Conclusions As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</description><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/tid.12197</identifier><identifier>PMID: 24628809</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Alternaria ; Amphotericin B - therapeutic use ; Antifungal Agents - therapeutic use ; Aureobasidium ; Brain Abscess - drug therapy ; Brain Abscess - microbiology ; Chaetomium ; Cladosporium ; Coniothyrium ; Debridement ; dematiaceous fungi ; Exophiala ; Female ; Humans ; Immunosuppression - adverse effects ; Itraconazole - therapeutic use ; Lung Abscess - drug therapy ; Lung Abscess - microbiology ; Male ; Middle Aged ; Opportunistic Infections - microbiology ; Opportunistic Infections - therapy ; Organ Transplantation - adverse effects ; phaeohyphomycosis ; Phaeohyphomycosis - microbiology ; Phaeohyphomycosis - therapy ; Phoma ; Retrospective Studies ; Time Factors ; transplantation ; Voriconazole - therapeutic use ; Wangiella ; Young Adult</subject><ispartof>Transplant infectious disease, 2014-04, Vol.16 (2), p.270-278</ispartof><rights>2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>2014 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</citedby><cites>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24628809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schieffelin, J.S.</creatorcontrib><creatorcontrib>Garcia-Diaz, J.B.</creatorcontrib><creatorcontrib>Loss Jr, G.E.</creatorcontrib><creatorcontrib>Beckman, E.N.</creatorcontrib><creatorcontrib>Keller, R.A.</creatorcontrib><creatorcontrib>Staffeld-Coit, C.</creatorcontrib><creatorcontrib>Garces, J.C.</creatorcontrib><creatorcontrib>Pankey, G.A.</creatorcontrib><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><description>Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009. Methods Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses. Results The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses. Conclusions As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</description><subject>Adult</subject><subject>Aged</subject><subject>Alternaria</subject><subject>Amphotericin B - therapeutic use</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aureobasidium</subject><subject>Brain Abscess - drug therapy</subject><subject>Brain Abscess - microbiology</subject><subject>Chaetomium</subject><subject>Cladosporium</subject><subject>Coniothyrium</subject><subject>Debridement</subject><subject>dematiaceous fungi</subject><subject>Exophiala</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppression - adverse effects</subject><subject>Itraconazole - therapeutic use</subject><subject>Lung Abscess - drug therapy</subject><subject>Lung Abscess - microbiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Opportunistic Infections - microbiology</subject><subject>Opportunistic Infections - therapy</subject><subject>Organ Transplantation - adverse effects</subject><subject>phaeohyphomycosis</subject><subject>Phaeohyphomycosis - microbiology</subject><subject>Phaeohyphomycosis - therapy</subject><subject>Phoma</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>transplantation</subject><subject>Voriconazole - therapeutic use</subject><subject>Wangiella</subject><subject>Young Adult</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkU9vFCEYhydGY__owS9gJvFSk07LCwwD3pqqa5Om9rDVxAthGdilzsAIM6nz7WW7bQ8mJnLhDTzPL5BfUbwBdAJ5nY6uPQEMonlW7AMRoiKI4ef3M68wbshecZDSLULQCCpeFnuYMsw5EvvFfL1RJmzmYRP6WYfkUmknv1Zd6bw1enTBpzyWKXSuLUNcK1-OUfk0dMqPZTTaDc74MX0odee809kcokn5SG3l43JQ4yZ0YT0fl8q3WTZq7PP1q-KFVV0yrx_2w-Lm86fl-Zfq8uvi4vzsstJUoKZSlCvNjOaCEwFIMQuIEVKvcM3BWm5Ua6lVRgtLG6IJBdBM14AxsxjQihwWR7vcIYZfk0mj7F3SpsvvN2FKEmqMCOeCwH-gQCmhDeCMvvsLvQ1T9PkjW4oQELhhmXq_o3QMKUVj5RBdr-IsAcltdTJXJ--ry-zbh8Rp1Zv2iXzsKgOnO-DOdWb-d5JcXnx8jKx2hkuj-f1kqPhTsoY0tfx-tZD46hshC_pDLskfzkizMA</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Schieffelin, J.S.</creator><creator>Garcia-Diaz, J.B.</creator><creator>Loss Jr, G.E.</creator><creator>Beckman, E.N.</creator><creator>Keller, R.A.</creator><creator>Staffeld-Coit, C.</creator><creator>Garces, J.C.</creator><creator>Pankey, G.A.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><author>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Alternaria</topic><topic>Amphotericin B - therapeutic use</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aureobasidium</topic><topic>Brain Abscess - drug therapy</topic><topic>Brain Abscess - microbiology</topic><topic>Chaetomium</topic><topic>Cladosporium</topic><topic>Coniothyrium</topic><topic>Debridement</topic><topic>dematiaceous fungi</topic><topic>Exophiala</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppression - adverse effects</topic><topic>Itraconazole - therapeutic use</topic><topic>Lung Abscess - drug therapy</topic><topic>Lung Abscess - microbiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Opportunistic Infections - microbiology</topic><topic>Opportunistic Infections - therapy</topic><topic>Organ Transplantation - adverse effects</topic><topic>phaeohyphomycosis</topic><topic>Phaeohyphomycosis - microbiology</topic><topic>Phaeohyphomycosis - therapy</topic><topic>Phoma</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>transplantation</topic><topic>Voriconazole - therapeutic use</topic><topic>Wangiella</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schieffelin, J.S.</creatorcontrib><creatorcontrib>Garcia-Diaz, J.B.</creatorcontrib><creatorcontrib>Loss Jr, G.E.</creatorcontrib><creatorcontrib>Beckman, E.N.</creatorcontrib><creatorcontrib>Keller, R.A.</creatorcontrib><creatorcontrib>Staffeld-Coit, C.</creatorcontrib><creatorcontrib>Garces, J.C.</creatorcontrib><creatorcontrib>Pankey, G.A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schieffelin, J.S.</au><au>Garcia-Diaz, J.B.</au><au>Loss Jr, G.E.</au><au>Beckman, E.N.</au><au>Keller, R.A.</au><au>Staffeld-Coit, C.</au><au>Garces, J.C.</au><au>Pankey, G.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2014-04</date><risdate>2014</risdate><volume>16</volume><issue>2</issue><spage>270</spage><epage>278</epage><pages>270-278</pages><issn>1398-2273</issn><eissn>1399-3062</eissn><abstract>Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009. Methods Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses. Results The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses. Conclusions As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>24628809</pmid><doi>10.1111/tid.12197</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1398-2273
ispartof Transplant infectious disease, 2014-04, Vol.16 (2), p.270-278
issn 1398-2273
1399-3062
language eng
recordid cdi_proquest_miscellaneous_1520388931
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Alternaria
Amphotericin B - therapeutic use
Antifungal Agents - therapeutic use
Aureobasidium
Brain Abscess - drug therapy
Brain Abscess - microbiology
Chaetomium
Cladosporium
Coniothyrium
Debridement
dematiaceous fungi
Exophiala
Female
Humans
Immunosuppression - adverse effects
Itraconazole - therapeutic use
Lung Abscess - drug therapy
Lung Abscess - microbiology
Male
Middle Aged
Opportunistic Infections - microbiology
Opportunistic Infections - therapy
Organ Transplantation - adverse effects
phaeohyphomycosis
Phaeohyphomycosis - microbiology
Phaeohyphomycosis - therapy
Phoma
Retrospective Studies
Time Factors
transplantation
Voriconazole - therapeutic use
Wangiella
Young Adult
title Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A45%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phaeohyphomycosis%20fungal%20infections%20in%20solid%20organ%20transplant%20recipients:%20clinical%20presentation,%20pathology,%20and%20treatment&rft.jtitle=Transplant%20infectious%20disease&rft.au=Schieffelin,%20J.S.&rft.date=2014-04&rft.volume=16&rft.issue=2&rft.spage=270&rft.epage=278&rft.pages=270-278&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/tid.12197&rft_dat=%3Cproquest_cross%3E1520388931%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1513319276&rft_id=info:pmid/24628809&rfr_iscdi=true